ABSTRACT Adrenal medullary chromaffin cells maintained in a chemically defined, serum-free medium retain high levels of both catecholamines and opiatelike peptides. At least 25% of the opioid activity as measured by radioreceptor assay is present as [Met-and [Leujenkephalin. Incubation of chromaffin cells with [3Htyrosine ad [S]methionine for 3 days results in incorporation of 'H and 35S into [Metlenkephalin and 3H incorporation into [Leujenkephalin, demonstrating de novo enkephalin synthesis. Addition of 100 nM reserpine to the culture medium causes an 80% depletion of catecholamines and a 100% increase in opioid peptide content 3-4 days later.
ABSTRACT Adrenal medullary chromaffin cells maintained in a chemically defined, serum-free medium retain high levels of both catecholamines and opiatelike peptides. At least 25% of the opioid activity as measured by radioreceptor assay is present as [Met- [Met]Enkephalin content is preferentially induced (290% above control) compared with [Leuenkephalin (70%). Reserpine increases the fractional radiolabling of [Met} and [Leulen- kephalin in excess of control cultures, suggesting that the increase in opiate-like peptides results from an increased rate of synthesis rather than decreased degradation, decreased secretion, or increased processing of preformed precursor(s).
Several laboratories have recently established the presence of large amounts of opiate-like peptides (OLP) in the adrenal medulla of several mammalian species, including man (1) (2) (3) (4) (5) . These OLP are stored with catecholamines in the storage vesicles of chromaffin cells and are secreted with catecholamines from the adrenal in response to splanchnic activation, acetylcholine, or other stimuli (3, 5) . Although the physiological function of the adrenomedullary enkephalins is unclear, stimuli that elicit catecholamine secretion from the gland also release large quantities of enkephalins into the circulation (5) .
Viveros et al. (5, 6) have demonstrated that the amounts of adrenomedullary enkephalins can be modified via splanchnic-adrenomedullary activation or after catecholamine depletion induced by reserpine. Insulin-induced hypoglycemia or reserpine treatment increases enkephalin levels within a few days. The reserpine-induced increase in OLP content is blocked by atio of cycloheximide (5, 7) or actinomycin D (7) , suggesting that this increase requires new peptide synthesis. In spite of these observations, there is no direct evidence for de novo synthesis of enkephalins by chromaffin cells nor is it known how reserpine and nerve stimulation increase the content of OLP. This could result from: (i) decreased rate of OLP degradation or secretion or both, (i) increased uptake of circulating enkephalins or precursor(s), (Mi) increased processing of a previously stored precursor, or (iv) increased translation and amino acid incorporation.
Synthesis of enkephalins from radiolabeled amino acids in vivo by rat brain (8) (9) (10) and in vitro by myenteric plexus (9) and striatal slices (11) (Fig. 1 A, B, and D) . On the basis of more detailed analytical studies carried out on the OLP extracted from homogenates of bovine adrenal medulla (3, 19) (2, 3, 21 ). At present, we can only speculate on the presence and nature of enkephalin precursors in the adrenal medulla. Further work is necessary to establish which of the many putative precursors described (2, 4, 5, 19, 22) In intact animals, neurogenic stimulation of the adrenal medulla or catecholamine depletion by reserpine results in induced synthesis of tyrosine hydroxylase and catecholamine storage vesicles, as monitored by an increase in dopaminef3-hydroxylase and vesicular catecholamine uptake (23, 24) .
This effect of reserpine is commonly thought to result from the decreased secretion of catecholamines leading to hypotension and reflex stimulation through the splanchnic nerve, and it has been called "trans-synaptic induction" (25) . We 7 ; unpublished data). Our results suggest that synaptic activation is not the only long-term regulator of enkephalin (and catecholamine) biosynthesis. This is in agreement with in vivo studies indicating that reserpine treatment leads to induction of dopamine-f3-hydroxylase at doses that do not produce synaptic activation or in the presence of ganglionic blocking agents (24) . A critical pool of catecholamines may be involved in the regulation of OLP levels in cultured chromaffin cells. Enkephalin levels in the striatum are also subject to regulation because various treatments produce increases in striatal enkephalin content (22, (27) (28) (29) . Although induction of adrenomedullary OLP by reserpine can occur without synaptic activation, increases in striatal enkephalins by decreased dopaminergic activation may require a multineuronal pathway (28) .
In conclusion, the data presented here demonstrate that adrenal medullary chromaffin cells maintained in culture can synthesize [Met] -and [Leu]enkephalin de novo and that OLP synthesis in these cells is subject to regulation. Elucidation of the reason for a physiological mechanism to control OLP synthesis in the adrenal medulla awaits an understanding of the neuroendocrine role of these peripherally released peptides.
Note Added in Proof. Using cultured chromaffin cells, Rossier et al.
